Cryoport (NASDAQ:CYRX) Releases Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Cryoport (NASDAQ:CYRX) issued its quarterly earnings results on Tuesday. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.09), Zacks reports. Cryoport had a negative return on equity of 13.35% and a negative net margin of 70.08%. Cryoport updated its FY 2025 guidance to EPS.

Cryoport Price Performance

NASDAQ:CYRX traded up $0.26 on Tuesday, hitting $5.06. The company had a trading volume of 960,643 shares, compared to its average volume of 285,872. Cryoport has a 52 week low of $4.58 and a 52 week high of $20.10. The company has a current ratio of 5.70, a quick ratio of 5.32 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $250.12 million, a price-to-earnings ratio of -1.50 and a beta of 1.59. The firm has a 50 day moving average of $7.39 and a two-hundred day moving average of $7.65.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Guggenheim started coverage on shares of Cryoport in a report on Thursday, December 19th. They issued a “buy” rating and a $11.00 target price on the stock. Needham & Company LLC reissued a “buy” rating and issued a $11.00 price objective on shares of Cryoport in a research note on Friday, January 17th. Finally, Roth Mkm lowered their price objective on shares of Cryoport from $18.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $12.29.

About Cryoport

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.